Get access
Clinical & Experimental Allergy

The evolution of oral immunotherapy for the treatment of peanut allergy

Authors

  • K. J. Allen,

    1. Genes, Environment and Health Theme, Murdoch Childrens Research Institute, Parkville, Vic., Australia
    2. Department of Paediatrics, The University of Melbourne, Carlton, Vic., Australia
    3. Department of Allergy and Immunology, The Royal Children's Hospital, Parkville, Vic., Australia
    Search for more papers by this author
  • R. E. O'Hehir

    1. Department of Allergy, Immunology & Respiratory Medicine, Alfred Hospital, Carlton, Vic., Australia
    2. Department of Clinical Immunology and Respiratory Medicine, Monash University, Carlton, Vic., Australia
    Search for more papers by this author

  • This editorial discusses the findings in the paper by Anagnostou et al. [8] pp. 1273–1281.

Correspondence:
K. J. Allen, Department of Allergy and Immunology, The Royal Children's Hospital, Flemington Road, Parkville, Vic. 3052, Australia.
E-mail: katie.allen@rch.org.au Cite this as: K. J. Allen and R. E. O'Hehir, Clinical & Experimental Allergy, 2011 (41) 1172–1174.

No abstract is available for this article.

Get access to the full text of this article

Ancillary